logo

Genomic Health Inc. (GHDX)



Trade GHDX now with
  Date
  Headline
9/28/2018 8:03:49 AM Genomic Health Publishes Clinical Evidence On Oncotype DX Genomic Prostate Score Test
9/12/2018 8:02:19 AM Epic Sciences Announces Completion Of $52 Mln Series E Financing
9/7/2018 8:05:00 AM Genomic Health: IQWiG Concludes Only Oncotype DX Has Evidence To Guide Breast Cancer Adjuvant Chemotherapy Decisions
9/7/2018 8:04:59 AM Genomic Health Announces Publication Of Updated Assessment Of Breast Cancer Gene Expression Profiling Tests By IQWiG
6/5/2018 10:04:23 AM GHDX: In The Pink Of Health
3/30/2018 8:04:55 AM Epic, Genomic Health Report Favorable Draft LCD On Medicare Coverage For Use Of Oncotype DX AR-V7 Nucleus Detect Test
3/13/2018 7:29:03 AM William Blair Is Cutting Genomic Health Inc. (GHDX) 2019 Rev. Estimate To 411.18 M From 414.37 M
3/13/2018 7:28:25 AM William Blair Is Cutting Genomic Health Inc. (GHDX) 2018 Rev. Estimate To 374.18 M From 382.28 M
3/12/2018 4:13:22 PM Illumina Names Phil Febbo As Chief Medical Officer
3/8/2018 8:15:18 AM Genomic Health Guides To Double-digit Revenue Growth And Full-year Profitability In 2018
2/26/2018 8:13:38 AM Genomic Health Announces U.S. Commercial Launch Of The Oncotype DX AR-V7 Nucleus Detect Test
12/20/2017 7:28:22 AM William Blair Cuts Genomic Health Inc. (GHDX) To Market Perform From Outperform
12/6/2017 8:13:48 AM Genomic Health To Collaborate With Janssen Pharma To Evaluate Oncotype DX Genomic Prostate Score Test
9/13/2017 1:01:39 AM Genomic Health, Biocartis To Develop Idylla IVD Oncotype DX Breast Cancer Test To Broaden Global Patient Access